Who is this Tempe joint guide for?

What can this guide honestly do?

It can help you name the painful movement, what eases it, and which warning signs need care. It can’t examine the joint, read your full history, or pick treatment for you. It also can’t say how long any relief might last, since that depends on your joint and your health.

Your doctor may know about old injuries, other illnesses, and medicines that change the answer. If general advice and your doctor’s advice differ, call and ask why.

Who pays for this guide?

The same people run this website and QC Kinetix clinics around Phoenix. Their clinic business funds the site and may make money if you book a consultation.

That business tie doesn’t show whether a treatment suits your joint. You’ll need to ask about cost, possible benefit, what isn’t known, and other choices before you agree.

When should you stop reading and call?

A hot, red, or quickly swollen joint needs prompt medical care. The same is true after major injury, with sudden loss of strength, or when numbness moves down a limb.

For slower soreness, call when sleep, walking, dressing, or chores keep getting harder. Take your medicines, old reports, and a note about the movements you can’t do now. Bring a friend along if remembering details is hard for you.

Sources

1. A Cochrane overview of 21 systematic reviews (381 studies, 37,143 participants) covering rheumatoid arthritis, osteoarthritis, fibromyalgia, low back pain, neck disorder and other chronic pain conditions concluded that physical activity and exercise are interventions with few adverse events that may improve pain severity and physical function - but that the quality of the evidence is low, effects on pain were inconsistent across reviews, and physical function improved significantly in 14 reviews with only small-to-moderate effect sizes. The commonest reported adverse event was increased muscle soreness that settled within weeks.

   Geneen LJ, Moore RA, Clarke C, Martin D, Colvin LA, Smith BH — Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews.. Cochrane Database of Systematic Reviews, 2017. DOI: 10.1002/14651858.CD011279.pub3.

2. OARSI's 2019 guideline is the only major osteoarthritis guideline that grades treatments separately for people with disease in MULTIPLE joints. Its Core Treatments for polyarticular OA are arthritis education and structured land-based exercise. Critically, intra-articular corticosteroid and intra-articular hyaluronic acid were Level 1B/2 options for knee OA only and were NOT recommended for hip or polyarticular OA; oral NSAIDs were not recommended at all for people with cardiovascular comorbidity or frailty; and paracetamol/acetaminophen was conditionally not recommended.

   Bannuru RR, Osani MC, Vaysbrot EE, et al. — OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis.. Osteoarthritis and Cartilage, 2019. DOI: 10.1016/j.joca.2019.06.011.

3. A meta-analysis of 20 dietary supplements across 69 randomised trials in hand, hip or knee osteoarthritis found that seven (collagen hydrolysate, passion fruit peel extract, Curcuma longa extract, Boswellia serrata extract, curcumin, pycnogenol and L-carnitine) showed large short-term effects on pain, and six more (undenatured type II collagen, avocado soybean unsaponifiables, methylsulfonylmethane, diacerein, glucosamine, chondroitin) showed statistically significant but clinically unclear effects. At MEDIUM term only green-lipped mussel extract and undenatured type II collagen retained clinically important effects, and NO supplement had a clinically important effect on pain at long term.

   Liu X, Machado GC, Eyles JP, Ravi V, Hunter DJ — Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis.. British Journal of Sports Medicine, 2018. DOI: 10.1136/bjsports-2016-097333.

4. Within the VITAL trial - 25,871 US adults randomised in a 2-by-2 factorial design to vitamin D and/or marine omega-3 fatty acids - a subgroup of 1,398 participants with pre-existing chronic knee pain (mean age 67.7, 66% women, mean WOMAC pain 37 of 100) was followed for a mean of 5.3 years. WOMAC pain did not differ between active vitamin D and its placebo, or between active omega-3 and its placebo, at any time point, and the time-by-treatment interactions were not significant. Function and stiffness gave the same answer.

   MacFarlane LA, Cook NR, Kim E, et al. — The Effects of Vitamin D and Marine Omega-3 Fatty Acid Supplementation on Chronic Knee Pain in Older US Adults: Results From a Randomized Trial.. Arthritis & Rheumatology, 2020. DOI: 10.1002/art.41416.